Molecular evidences of activating mutations of the JAK/STAT inflammatory pathway in BI-ALCL samples [18], [46] and of a higher (although not statistically significant) percentage of CD30+ cells detected in the chronic seromas support this hypothesis. The gene discussed is SOAT1; the disease is anaplastic large cell lymphoma.